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Purpose: The Accreditation Council for Graduate Medical Education (ACGME) next
accreditation system (NAS) provides incentive for medical educators to understand and
implement competency-based medical education (CBME) training and assessment in
their programs. Noting decreasing enrollees for the American Board of Internal
Medicine (ABIM) Transplant Hepatology (TH) exam, workforce concerns in TH, and
questionnaire data from Gastroenterology (GI) fellows and Program Directors (PDs), we
developed an ABIM-approved one-year competency- based TH pilot program.
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Designed in consultation with and approved by the American Board of
Internal Medicine (ABIM), Our pilot employs a hybrid design of the ABIM/
ACGME milestones model1 and the entrustable professional activities
model (EPA) of ten Cate2. The use of milestones insures that training
meets ACGME competencies. Our milestones grid for the Patient Care
competency is illustrated below.
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The expected timeline to achieve the “statement of awarded
responsibility (STAR) for each of the 14 EPAs in our pilot training program
is illustrated below:

&$)&)$"&"+%#
Although the specific structure of any given pilot program participant will
depend on the institution, out design stipulates that each program have a
Competence Committee, consisting of the Program Director and at least
two other Transplant hepatology faculty, which meets quarterly and
reviews the assessments listed in the table below. Committee feedback
and action are to be provided to the trainee in a timely fashion.

Methods/Results: Responding to a Multi-society Task Force on GI Training
recommendation that Board Certification in TH be abandoned in favor of a “Focused
Recognition” model and survey results suggesting that training duration had a
detrimental effect on retaining trainees’ interest in TH careers, a competency-based
three year combined GI/TH program was proposed, followed by participation in an
ABIM workshop exploring CBME program development. The authors then participated in
an ABIM “just-in-time” faculty development session.
Our pilot employs a hybrid design of the ABIM/ACGME milestones model1 and the
entrustable professional activities model (EPA) of ten Cate2. Our 14 EPAs include
management of disorders frequently seen at a referral liver center. The pilot utilizes a
one-year time frame, is approved for ten years and will start enrolling trainees in July
2012. Any institution with an ACGME-approved TH program is eligible to participate.
Trainees must be certified as competent (using traditional methods) in GI as a prerequisite to enrollment. Faculty development will be available at national meetings
and participating institutions. Outcomes measures include trainee achievement of level
4 or 5 entrustability for EPAs, TH Board Examination pass rate, Care Transition Measure
instrument (CTM-3) scores, trainees’ participation in continuous maintenance of
certification activities, hospital readmission rates and hospital CAHPS scores.
Conclusions: In an effort to respond to workforce needs while meeting ACGME NAS
requirements, we developed a CBME-based one year program in TH. We anticipate that
both GI and TH training can be completed in three years and that the lessons learned
from the early implementation of our CBME-based program will be generalizable to
other areas of Graduate Medical Education.
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The experience of program directors around the country and a decreasing
number of enrollees for the ABIM Transplant Hepatology Board exam led to
exploration of potential barriers to this career path. As exemplified by the
responses below, GI fellow interest in Transplant Hepatology is high, but
the additional year of training tends to discourage pursuit of the
subspecialty. TH program directors agreed that a decreased period of
training could still result in suitable training of candidates
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We chose a variety of outcomes measures to assess the progress of
trainees and reproducibility across institutions. Use of these instruments
required a manageable amount of faculty development, which will be
provided both by ABIM and AASLD

The concept of entrustable professional activities (EPAs) provides a
framework for assessment that can be conducted in the course of
clinical practice.
Our 14 EPAs include management of disorders
frequently seen at a referral liver center. Examples of our EPAs for the
management of portal hypertensive hemorrhage and compensated
cirrhosis are illustrated below. Scoring of EPAs is based on a five point
scale, with a score of 4 indicative of competence.
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The Transplant Hepatology Pilot Program, designed using the assessment
methods of Competency Based Medical Education, will allow more robust
and reproducible training of future transplant hepatologists. We anticipate
that the potential for reduced training time will increase the number of
candidates for TH training and eventual TH Board Certification. Our hope
is that our experience will provide valuable information for medical
educators in other specialty areas.
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